Kintsugi(US) | $6,000,000 | (May 31, 2024)
Valar Labs | $22,000,000 | (May 31, 2024)
Plural Energy | $2,330,000 | (May 31, 2024)
Gallant Therapeutics
United States
- SAN DIEGO, CA
- 09/01/2024
- Series A
- $15,000,000
Gallant Therapeutics is a clinical-stage animal health biotechnology company setting a new standard in animal health by harnessing the power of stem cell therapy to treat the root cause of diseases in dogs and cats. Our pipeline of off-the-shelf mesenchymal stem cell (MSC) therapies has the potential to treat a broad range of diseases, including canine and feline osteoarthritis (OA), feline chronic kidney disease (CKD), and others. The first product based on our uterine-derived platform for feline chronic gingivostomatitis (FCGS), is on track for conditional approval by the FDA in 2025. United by a love of and commitment to animals, Gallant’s team includes industry pioneers in veterinary regenerative medicine with deep experience in cell therapy product development, manufacturing and commercialization.
- Industry Biotechnology Research
- Website https://www.gallanttherapeutics.com/
- LinkedIn https://www.linkedin.com/company/gallanttherapeutics/about/
Related People
Linda BlackFounder
United States -
San Diego County, California
On the day my childhood horse almost died, I decided to become a veterinarian. As I grew as a professional, I uncovered my love for science and research and, ultimately, regenerative medicine.
Along the way, I learned a lot about leadership, what makes a good team, how to care for them, and how to inspire people to reach for something far bigger than themselves.
Today, I use these learnings to lead a team of pioneers in a field that we believe will transform animal health.
Professionally, I excel at:
- Creating a values-based culture
- Compassionate leadership
- Putting people at the center of all that I do
- Innovative science
- Being calm in a crisis
- Accountability- the buck stops with me
Personally, I am:
- Passionate about personal development
- Writing obsessed
- A fitness/well-being fanatic
- A mom before all…
I love the fact that I work with incredible people on a mission to create a new class of therapies for our pets that treat the root cause of disease and have the potential to alter their quality of life and, therefore ours ❤️
HoundDog.ai | $3,100,000 | (May 31, 2024)
Fortunafi | $9,500,000 | (May 31, 2024)
Faircado | $3,252,930 | (May 31, 2024)
Basalt Tech | $3,500,000 | (May 31, 2024)
FintechOS | $60,000,000 | (May 31, 2024)
Remark | $10,300,000 | (May 31, 2024)
Revive | $3,500,000 | (May 31, 2024)
Viable(UK) | $3,100,000 | (May 31, 2024)
Weave | $10,000,000 | (May 31, 2024)